代谢脆弱性指数和动脉样硬化事件:英国生物银行的一项前性队列研究
Xiangliang Liu1, Xinqiao Chen1, Wang Yang1
1Cancer Center The First Hospital of Jilin University Changchun China.
Journal of the American Heart Association
|November 12, 2025
概括
一个新的代谢脆弱性指数 (MVX),结合炎症和代谢标记,预测动脉样硬化风险独立于传统因素. 这突显了炎症.
科学领域:
- 心血管疾病研究研究
- 生物标志物发现发现
- 代谢学 代谢学 代谢学
背景情况:
- 动脉样硬化是心血管疾病的主要驱动因素.
- 传统的风险因素不能完全解释个体风险.
- 需要新的生物标志物来改善风险预测.
研究的目的:
- 评估新型代谢脆弱性指数 (MVX) 对发生动脉样硬化的预测价值.
- 确定MVX是否提供超越传统和遗传风险因素的独立预测价值.
主要方法:
- 分析了来自171,600名参与者的英国生物库数据.
- MVX来源于代谢组分,包括炎症和代谢组分.
- 考克斯模型用于评估发生动脉样硬化的关联.
主要成果:
- 较高的MVX显著预测了动脉样硬化风险的增加 (HR per SD: 1.22).
- 最高的MVX四分位数显示,与最低的四分位数相比,风险增加了59%.
- 在调整为传统风险因素和跨遗传风险层之后,关联仍然很重要.
结论:
- MVX,特别是它的炎症成分,可以独立预测动脉样硬化风险.
- 综合的代谢分析可以完善心血管风险评估.
- 炎症在动脉样硬化中起着关键作用,这表明了潜在的治疗点.
相关概念视频
Bias in Epidemiological Studies
1.7K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.7K
Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Atherosclerosis I: Introduction
2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
948
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17


